On behalf of the four regional health authorities, Sykehusinnkjøp HF, division pharmaceuticals, is considering to procure the active ingredient teduglutide. Sykehusinnkjøp would like to invite inetessenter to dialogue meetings to update us in the market. The meetings will be held via Teams 23 September 2026.Vi ask interested parties to register their interest in such a dialogue meeting via the communication module in Ivalua by 11 September 2026.